TA
$83.21
+0.44
(+0.54%)
As of Sep 5, 2026, 10:32 AM EDT · cached
Price history
Tarsus Pharmaceuticals Inc (TARS) is trading up at $83.21 (+0.54%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.
IPO: October 16, 2020 · $16.00 offering · NASDAQ · View IPO details →
Recent News (7)
-
Tarsus Pharmaceuticals stock hits all-time high at 85.29 USD
Tarsus Pharmaceuticals stock hits all-time high at 85.29 USD
-
Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care Adds gildeuretinol (ALK-001), a differentiated Phase 3 oral investigational medicine designed to target the underlying biology of Stargardt’s disease, a potentially blinding disease with no FDA-approv…
-
-
Tarsus (TARS) Results Check: The EPS Result Is Below Expectation in the Reported Period; Market Response: The Share Price Adds 0.16% in the Latest Session - EPS Consistency Score Tarsus (TARS) Results Check: The EPS Result Is Below Expectation in the Reported Period; Market Response: The Share Price Adds 0.16% in the Latest Session - EPS Consistency Score vinanet.vn
-
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position Adds a potential blockbuster opportunity with gildeuretinol (ALK-001), a differentiated Phase 3 oral investigational medicine designed to target the underlying biology of Stargardt disease, one of the…
-
-
More Health Care stocks
- AZN AstraZeneca
- ILMN Illumina
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- AMGN Amgen
- BAX Baxter International